← FDA DRUG APPROVALS

FDA ANDA · ANDA061578

POLY-RX

Sponsor: X GEN PHARMS

APPLICATION
ANDA061578
TYPE
ANDA
ORIGINAL APPROVAL
1972-01-05
LATEST ACTION
2001-12-06
ROUTE
FOR RX COMPOUNDING
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

POLY-RXDiscontinued
POLYMYXIN B SULFATE 100,000,000 UNITS/BOT · POWDER · FOR RX COMPOUNDING

Approval history

2001-12-06Manufacturing (CMC) · Supplement 5AP
2001-04-27Manufacturing (CMC) · Supplement 4AP
1999-11-15Manufacturing (CMC) · Supplement 3AP
1994-07-29Manufacturing (CMC) · Supplement 1AP
1994-06-20Manufacturing (CMC) · Supplement 2AP
1972-01-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →